
|Videos|June 22, 2023
Other Bispecific Antibodies Under Investigation for Treatment of Relapsed Multiple Myeloma
Naresh Bumma, MD, details other bispecific agents on the horizon for relapsed multiple myeloma treatment.
Advertisement
Episodes in this series

Advertisement
Advertisement
Advertisement
Trending on CancerNetwork
1
FDA Approves Afami-cel in Metastatic Synovial Sarcoma
2
The Moonlight Shift: Dr Joshua Richter on Myeloma, Myths, and the C-Word
3
How Are Key Lymphoma Data From ASCO and EHA 2026 Shaping Treatment?
4
Binimetinib Tablets Receive Tentative FDA Approval in Melanoma/NSCLC
5


















































































